Abstract:Hypoxia is a condition commonly observed in the core of solid tumors. The hypoxia-inducible factors (HIF) act as hypoxia sensors that orchestrate a coordinated response increasing the pro-survival and pro-invasive phenotype of cancer cells, and determine a broad metabolic rewiring. These events favor tumor progression and chemoresistance. The increase in glucose and amino acid uptake, glycolytic flux, and lactate production; the alterations in glutamine metabolism, tricarboxylic acid cycle, and oxidative phosphorylation; the high levels of mitochondrial reactive oxygen species; the modulation of both fatty acid synthesis and oxidation are hallmarks of the metabolic rewiring induced by hypoxia. This review discusses how metabolic-dependent factors (e.g., increased acidification of tumor microenvironment coupled with intracellular alkalinization, and reduced mitochondrial metabolism), and metabolic-independent factors (e.g., increased expression of drug efflux transporters, stemness maintenance, and epithelial-mesenchymal transition) cooperate in determining chemoresistance in hypoxia. Specific metabolic modifiers, however, can reverse the metabolic phenotype of hypoxic tumor areas that are more chemoresistant into the phenotype typical of chemosensitive cells. We propose these metabolic modifiers, able to reverse the hypoxia-induced metabolic rewiring, as potential chemosensitizer agents against hypoxic and refractory tumor cells.

Hypoxia and Metabolism in Metastasis

Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer Therapy

Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications

Metabolomic Investigations into Hypoxia-Mediated Metabolic Reprogramming of Pancreatic Cancer Cells

Hypoxia Boosts Aerobic Glycolysis in Carcinoma: A Complex Process for Tumour Development

The hypoxic tumour microenvironment and metastatic progression

Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes

Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target

Central role of hypoxia-inducible factor-1α in metabolic reprogramming of cancer cells: A review

The cellular-centered view of hypoxia tumor microenvironment: Molecular mechanisms and therapeutic interventions

Hypoxia: Intriguing Feature in Cancer Cell Biology

Hypoxia Signaling in Cancer: Implications for Therapeutic Interventions

Tumor hypoxia: From basic knowledge to therapeutic implications

Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance

Hypoxia and the Tumor Microenvironment

Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression

Role of hypoxia in the tumor microenvironment and targeted therapy

HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies

Role of hypoxia in cancer therapy by regulating the tumor microenvironment

Interplay of long non-coding RNAs and HIF-1α: A new dimension to understanding hypoxia-regulated tumor growth and metastasis

Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?